Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 102.56% | 102.56% | 117.23% | 117.23% | -1,381.94% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.22% | -104.22% | -130.79% | -130.79% | 1,884.37% |
| Change in Net Operating Assets | -25.00% | -25.00% | -180.00% | -180.00% | 96.69% |
| Cash from Operations | 13.99% | 13.99% | 2.63% | 2.63% | 27.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.09% | 9.09% | -92.99% | -92.99% | 101.12% |
| Cash from Investing | 9.09% | 9.09% | -92.99% | -92.99% | 101.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 59.26% | 59.26% | 11.29% | 11.29% | 258.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.47% | 24.47% | -112.93% | -112.93% | 90.03% |